Too right Musky. The sales team would have been building interest in and pre selling VascuCel for the last 6 months if not longer. I am not a champion sales person but even I know that this is how you "launch" a new product.
Unlike CardioCel (where we had a "cold" start) we are going into this with an experienced and incentivised sales team, sales targets, existing hospital accounts, established customer relationships and extensive data on safety and performance of the ADAPT process.
While we need to keep our expectations in check, with competitors having issues and our results continuing to be top notch, it's a great time to launch VascuCel. Exciting times ahead.
- Forums
- ASX - By Stock
- AVR
- AHZ
AHZ, page-303
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.00 |
Change
-0.500(3.23%) |
Mkt cap ! $322.1M |
Open | High | Low | Value | Volume |
$15.50 | $15.50 | $14.80 | $125.1K | 8.313K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 383 | $15.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.25 | 1331 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 114 | 14.800 |
1 | 1000 | 14.750 |
1 | 25 | 14.640 |
1 | 206 | 14.500 |
1 | 1388 | 14.400 |
Price($) | Vol. | No. |
---|---|---|
15.000 | 171 | 3 |
15.250 | 1319 | 4 |
15.400 | 238 | 1 |
15.500 | 370 | 1 |
15.660 | 1925 | 2 |
Last trade - 15.27pm 23/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online